Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

MLA

Bonderman, Diana, et al. “Acute Hemodynamic Effects of Riociguat in Patients with Pulmonary Hypertension Associated with Diastolic Heart Failure (DILATE-1): A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study.” Chest, vol. 146, no. 5, Nov. 2014, pp. 1274–85. EBSCOhost, https://doi.org/10.1378/chest.14-0106.

APA

Bonderman, D., Pretsch, I., Steringer-Mascherbauer, R., Jansa, P., Rosenkranz, S., Tufaro, C., Bojic, A., Lam, C. S. P., Frey, R., Ochan Kilama, M., Unger, S., Roessig, L., & Lang, I. M. (2014). Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. Chest, 146(5), 1274–1285. https://doi.org/10.1378/chest.14-0106

Chicago

Bonderman, Diana, Ingrid Pretsch, Regina Steringer-Mascherbauer, Pavel Jansa, Stephan Rosenkranz, Caroline Tufaro, Andja Bojic, et al. 2014. “Acute Hemodynamic Effects of Riociguat in Patients with Pulmonary Hypertension Associated with Diastolic Heart Failure (DILATE-1): A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study.” Chest 146 (5): 1274–85. doi:10.1378/chest.14-0106.